Externally Delivered Focused Ultrasound for Renal Denervation

JACC: Cardiovascular Interventions

Volumn 9, Issue 12, 2016, Pages 1292-1299

  Neuzil, Petr ^a   Ormiston, John ^b   Brinton, Todd J ^c   Starek, Zdenek ^d   Esler, Murray ^e   Dawood, Omar ^f   Anderson, Thomas L ^f   Gertner, Michael ^f   Whitbourne, Rob ^g   Schmieder, Roland E ^h  

^a Homolce Hosp   (Czech Republic)

^b Mercy Hospital   (New Zealand)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^f Kona Medical   (United States)

^g ST VINCENT S HOSPITAL   (Australia)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

noninvasive; renal denervation; safety; treatment resistant hypertension; ultrasound

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ANGIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BACKACHE; BLOOD PRESSURE MEASUREMENT; CLINICAL ASSESSMENT; ECHOGRAPHY; EDEMA; FEMALE; FOLLOW UP; HUMAN; HYPEREMIA; HYPERTENSION; HYPOTENSION; KIDNEY DENERVATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESISTANT HYPERTENSION; ULTRASOUND TRANSDUCER; AGED; AUSTRALIA; AUTONOMIC DENERVATION; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; DEVICES; DRUG EFFECTS; DRUG RESISTANCE; DUPLEX DOPPLER ULTRASONOGRAPHY; EQUIPMENT DESIGN; EUROPE; HIGH INTENSITY FOCUSED ULTRASOUND; INNERVATION; KIDNEY; KIDNEY ARTERY; MIDDLE AGED; NEW ZEALAND; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SURGICAL EQUIPMENT; TIME FACTOR; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ANGIOGRAPHY; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; AUTONOMIC DENERVATION; BLOOD PRESSURE; DRUG RESISTANCE; EQUIPMENT DESIGN; EUROPE; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; HYPERTENSION; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEW ZEALAND; RENAL ARTERY; SURGICAL EQUIPMENT; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84993970057     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.04.013     Document Type: Article

References (14)

1. 1 Judd, E., Calhoun, D.A., Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens 28 (2014), 463–468.
2. 2 Symplicity HTN Investigators, Esler, M.D., Krum, H., et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial. Lancet 376 (2010), 1903–1909.
3. 3 Thorp, A.A., Schlaich, M.P., Device-based approaches for renal nerve ablation for hypertension and beyond. Front Physiol, 6, 2015, 193.
4. 4 Azizi, M., Sapoval, M., Gosse, P., et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385 (2015), 1957–1965.
5. 5 Oparil, S., Schmieder, R.E., New approaches in the treatment of hypertension. Circ Res 116 (2015), 1074–1095.
6. 6 Mahfoud, F., Bohm, M., Azizi, M., et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Eur Heart J 36 (2015), 2219–2227.
7. 7 Mancia, G., Fagard, R., Narkiewicz, K., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34 (2013), 2159–2219.
8. 8 Mahfoud, F., Edelman, E.R., Bohm, M., Catheter-based renal denervation is no simple matter: lessons to be learned from our anatomy?. J Am Coll Cardiol 64 (2014), 644–646.
9. 9 Kandzari, D.E., Bhatt, D.L., Brar, S., et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 36 (2015), 219–227.
10. 10 Tsioufis, C., Mahfoud, F., Mancia, G., et al. What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention 9 (2014), 1027–1035.
11. 11 Bohm, M., Mahfoud, F., Ukena, C., et al. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension 65 (2015), 766–774.
12. 12 Mahfoud, F., Ukena, C., Schmieder, R.E., et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 128 (2013), 132–140.
13. 13 Schmieder, R.E., Schmidt, S.T., Riemer, T., et al. Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels. Hypertension 64 (2014), 1067–1072.
14. 14 Messerli, F.H., Bangalore, S., Schmieder, R.E., Wilder's principle: pre-treatment value determines post-treatment response. Eur Heart J 36 (2015), 576–579.